284030-57-5 Usage
General Description
4-AMINO-2,3-DIFLUORO-5-NITRO-BENZOIC ACID is a chemical compound with the molecular formula C7H4F2N2O4. It is a derivative of benzoic acid with a nitro group and two fluorine atoms attached to the aromatic ring. 4-AMINO-2,3-DIFLUORO-5-NITRO-BENZOIC ACID is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceuticals. It possesses antibacterial and antifungal properties, making it a valuable component in the development of medications to treat infections. Additionally, it is also used in the manufacturing of dyes and pigments. Due to its chemical properties, it is important to handle 4-AMINO-2,3-DIFLUORO-5-NITRO-BENZOIC ACID with caution and follow proper safety protocols when working with it.
Check Digit Verification of cas no
The CAS Registry Mumber 284030-57-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,0,3 and 0 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 284030-57:
(8*2)+(7*8)+(6*4)+(5*0)+(4*3)+(3*0)+(2*5)+(1*7)=125
125 % 10 = 5
So 284030-57-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H4F2N2O4/c8-4-2(7(12)13)1-3(11(14)15)6(10)5(4)9/h1H,10H2,(H,12,13)
284030-57-5Relevant articles and documents
FORMS OF BINIMETINIB AND PROCESS FOR PREPARATION THEREOF
-
, (2021/06/22)
Amorphous forms of Binimetinib and processes for the preparation thereof.
COMBINATION THERAPY
-
, (2013/10/08)
The present invention relates to a pharmaceutical combination comprising a MEK inhibitor compound 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)- amide or a pharmaceutically acceptable salt thereof and the IGFIR inhibitor ANTIBODY A, a pharmaceutical composition comprising such combination, methods for treating cancer comprising administration of a therapeutically effective amount of such combination to a subject in need thereof, and uses of such combination for the treatment of cancer.
SNAr PROCESS FOR PREPARING BENZIMIDAZOLE COMPOUNDS
-
Page/Page column 50, (2010/11/25)
Provided are methods for the synthesis of heterocyclic compounds such as benzimidazole carboxylic acid core structures having Formula Ia-2 and their synthetic intermediates: wherein X1, X2, X5, R1, R2 and R4 are as defined herein. Compounds of Formula Ia-2 and their synthetic intermediates can be used to prepare heterocyclic derivatives such as benzimidazole derivatives.
